MAP2K1 and colorectal cancer: While colorectal cancer cell lines have been frequently observed to display synergistic response to combined inhibition of MAP2K1/2 (MEK1/2) and PI3K27–30, weaker synergy has previously been observed in SW-620 and COLO 205 cells28.